JP2020511515A5 - - Google Patents

Download PDF

Info

Publication number
JP2020511515A5
JP2020511515A5 JP2019552238A JP2019552238A JP2020511515A5 JP 2020511515 A5 JP2020511515 A5 JP 2020511515A5 JP 2019552238 A JP2019552238 A JP 2019552238A JP 2019552238 A JP2019552238 A JP 2019552238A JP 2020511515 A5 JP2020511515 A5 JP 2020511515A5
Authority
JP
Japan
Prior art keywords
pyrrole
ethyl
hexahydropyrrolo
diethyl
dihydrofuran
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019552238A
Other languages
English (en)
Japanese (ja)
Other versions
JP2020511515A (ja
JP7365238B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/022581 external-priority patent/WO2018175190A1/en
Publication of JP2020511515A publication Critical patent/JP2020511515A/ja
Publication of JP2020511515A5 publication Critical patent/JP2020511515A5/ja
Priority to JP2023174457A priority Critical patent/JP7705909B2/ja
Application granted granted Critical
Publication of JP7365238B2 publication Critical patent/JP7365238B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019552238A 2017-03-21 2018-03-15 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用 Active JP7365238B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2023174457A JP7705909B2 (ja) 2017-03-21 2023-10-06 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762474280P 2017-03-21 2017-03-21
US62/474,280 2017-03-21
PCT/US2018/022581 WO2018175190A1 (en) 2017-03-21 2018-03-15 5-hydroxytryptamine receptor 7 modulators and their use as therapeutic agents

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2023174457A Division JP7705909B2 (ja) 2017-03-21 2023-10-06 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用

Publications (3)

Publication Number Publication Date
JP2020511515A JP2020511515A (ja) 2020-04-16
JP2020511515A5 true JP2020511515A5 (cg-RX-API-DMAC7.html) 2021-04-22
JP7365238B2 JP7365238B2 (ja) 2023-10-19

Family

ID=63585688

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2019552238A Active JP7365238B2 (ja) 2017-03-21 2018-03-15 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用
JP2023174457A Active JP7705909B2 (ja) 2017-03-21 2023-10-06 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2023174457A Active JP7705909B2 (ja) 2017-03-21 2023-10-06 5-ヒドロキシトリプタミン受容体7調節物質および治療剤としてのその使用

Country Status (5)

Country Link
US (3) US11220505B2 (cg-RX-API-DMAC7.html)
EP (1) EP3600289A4 (cg-RX-API-DMAC7.html)
JP (2) JP7365238B2 (cg-RX-API-DMAC7.html)
MA (1) MA49017A (cg-RX-API-DMAC7.html)
WO (1) WO2018175190A1 (cg-RX-API-DMAC7.html)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
US10858368B2 (en) 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
JP7365237B2 (ja) 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション シグマ-2受容体の新規調節物質およびその使用方法
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS
WO2019217890A1 (en) * 2018-05-11 2019-11-14 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use
GB201809295D0 (en) * 2018-06-06 2018-07-25 Institute Of Cancer Res Royal Cancer Hospital Lox inhibitors
CN112010859B (zh) * 2019-05-30 2022-07-19 中国科学院上海药物研究所 一种并环化合物、其制备方法和用途
MX2022005819A (es) * 2019-11-13 2022-08-16 Univ Temple Nuevas lactonas funcionalizadas como moduladores del receptor 7 de 5-hidroxitriptamina y su método de uso.
CN115003675A (zh) * 2019-11-13 2022-09-02 英联邦高等教育系统坦普尔大学 作为5-羟色胺受体7调节剂的新型官能化内酰胺及其使用方法

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2514656A1 (en) 2003-01-31 2004-08-12 Pfizer Products Inc. 5ht7 antagonists and inverse agonists
AU2005219438B2 (en) * 2004-03-03 2011-02-17 Chemocentryx, Inc. Bicyclic and bridged nitrogen heterocycles
GB0419192D0 (en) 2004-08-27 2004-09-29 Merck Sharp & Dohme Therapeutic agents
EP1875899A1 (en) 2006-06-29 2008-01-09 Laboratorios Del Dr. Esteve, S.A. Use of 5HT7 receptor agonists for the treatment of pain
JP2010509402A (ja) * 2006-11-13 2010-03-25 キング・ファーマシューティカルズ・リサーチ・アンド・デベロプメント・インコーポレイティッド A1アデノシン受容体のアロステリック調節剤
CN101821257B (zh) 2007-10-12 2013-05-22 伊莱利利公司 5-ht7受体拮抗剂
US8148408B2 (en) * 2008-05-09 2012-04-03 Abbott Laboratories Selective substituted pyridine ligands for neuronal nicotinic receptors
US20100069390A1 (en) 2008-09-05 2010-03-18 Supernus Pharmaceuticals, Inc. Method of treatment of attention deficit/hyperactivity disorder (ADHD)
WO2012058769A1 (en) 2010-11-03 2012-05-10 Mcmaster University Method of treating mucosal inflammation
US8697888B2 (en) * 2012-01-06 2014-04-15 Vanderbilt University Substituted (1-(methylsulfonyl)azetidin-3-yl)(heterocycloalkyl)methanone analogs as antagonists of muscarinic acetylcholine M1 receptors
WO2014085413A1 (en) 2012-11-28 2014-06-05 Temple University - Of The Commonwealth System Of Higher Education Disubstituted oxazolidin-2-ones 5-hydroxytryptamine receptor 2b activity modulators
EP2928474B1 (en) * 2012-12-07 2018-11-14 ChemoCentryx, Inc. Diazole lactams
US9802924B2 (en) 2013-03-11 2017-10-31 Temple University Of The Commonwealth System Of Higher Education 5-hydroxytryptamine receptor 7 activity modulators and their method of use
KR20160098506A (ko) 2013-12-20 2016-08-18 라보라토리오스 델 드라. 에스테브.에스.에이. 통증에 대한 다양한 활성을 갖는 피페라진 유도체
EP3200589B1 (en) 2014-09-10 2026-03-11 Temple University Of The Commonwealth System Of Higher Education Novel 5-hydroxytryptamine receptor 7 activity modulators and their method of use
TWI698436B (zh) 2014-12-30 2020-07-11 美商佛瑪治療公司 作為泛素特異性蛋白酶7抑制劑之吡咯并及吡唑并嘧啶
US20180221365A1 (en) 2015-05-12 2018-08-09 Temple University-Of The Commonwealth System Of Higher Education Novel sigma-2 receptor binders and their method of use
US10858368B2 (en) * 2016-11-15 2020-12-08 Temple University—Of the Commonwealth System of Higher Education Modulators of the 5-hydroxytryptamine receptor 7 and their method of use
EP3600289A4 (en) 2017-03-21 2020-08-05 Temple University - Of The Commonwealth System of Higher Education 5-HYDROXYTRYPTAMINE RECEPTOR 7 MODULATORS AND THE USE OF THESE AS THERAPEUTIC AGENTS
JP7365237B2 (ja) * 2017-03-21 2023-10-19 テンプル・ユニバーシティ-オブ・ザ・コモンウェルス・システム・オブ・ハイアー・エデュケイション シグマ-2受容体の新規調節物質およびその使用方法
WO2019217890A1 (en) 2018-05-11 2019-11-14 Temple University-Of The Commonwealth System Of Higher Education Novel functionalized lactams as modulators of the 5-hydroxytryptamine receptor 7 and their method of use

Similar Documents

Publication Publication Date Title
US11401259B2 (en) 1-Pyridazin-/triazin-3-yl-piper(-azine)/idine/pyrolidine derivatives and compositions thereof for inhibiting the activity of SHP2
CN103930399B (zh) 包含亚氨基亚磺酰基的二取代的5-氟嘧啶衍生物
ES2741746T3 (es) Compuestos y composiciones para inhibir la actividad de SHP2
KR101958501B1 (ko) 설폭시민기 함유 4-아릴-n-페닐-1,3,5-트리아진-2-아민
JP2020511506A5 (cg-RX-API-DMAC7.html)
CN105102444B (zh) 含磺亚胺基的5‑氟‑n‑(吡啶‑2‑基)吡啶‑2‑胺衍生物
JP2012522847A5 (cg-RX-API-DMAC7.html)
JP6300818B2 (ja) スルホキシイミン基を含有する4−(オルト)−フルオロフェニル−5−フルオロピリミジン−2−イルアミン
CN103917527B (zh) 二取代的5‑氟‑嘧啶
EP3681879A1 (en) Octahydrocyclopenta[c]pyrrole allosteric inhibitors of shp2
JP2018507877A5 (cg-RX-API-DMAC7.html)
CN104918932B (zh) 含磺亚胺基团的n‑(吡啶‑2‑基)嘧啶‑4‑胺衍生物
JP2019535825A5 (cg-RX-API-DMAC7.html)
JP2019512474A (ja) シアノ置換インドール化合物およびlsd1阻害剤としてのその使用
TW201211049A (en) Substituted imidazopyridazines
CN102725283A (zh) 作为蛋白激酶抑制剂的化合物和组合物
JP2009536161A5 (cg-RX-API-DMAC7.html)
CN105102434A (zh) 含砜基团的4-(邻)-氟苯基-5-氟嘧啶-2-基胺
CN103124730A (zh) 杂环炔苯类化合物及其药用组合物和应用
TW200914431A (en) Novel morpholine compounds
JP2017508757A (ja) スルホン基を含有する5−フルオロ−n−(ピリジン−2−イル)ピリジン−2−アミン誘導体
EP3016945A1 (en) Sulfoximine substituted 5-fluoro-n-(pyridin-2-yl)pyridin-2-amine derivatives and their use as cdk9 kinase inhibitors
CA2952526A1 (en) Bet-protein inhibiting 3,4-dihydropyrido[2,3-b]pyrazinones with meta-substituted aromatic amino- or ether groups
JP2020535172A5 (cg-RX-API-DMAC7.html)
JP2022535072A5 (cg-RX-API-DMAC7.html)